Clinical studies [82] found that increased urinary WNT4 expression was detected earlier than serum creatinine and epidermal growth factor receptor in patients with contrast-induced AKI after vascular intervention [85], suggesting that urinary WNT4 could potentially serve as a noninvasive biomarker for monitoring patients with tubular injury. The gene discussed is WNT4; the disease is acute kidney injury.